Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.

  • Neurogene's Income towards Parent Company fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Income towards Parent Company is -$21.1 million, which was down 365.48% from -$23.2 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Income towards Parent Company ranged from a high of -$11.9 million in Q2 2023 and a low of -$23.2 million during Q2 2025
  • For the 3-year period, Neurogene's Income towards Parent Company averaged around -$17.8 million, with its median value being -$18.6 million (2024).
  • In the last 5 years, Neurogene's Income towards Parent Company crashed by 5713.92% in 2024 and then plummeted by 365.48% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Income towards Parent Company stood at -$14.0 million in 2023, then tumbled by 40.71% to -$19.7 million in 2024, then decreased by 7.35% to -$21.1 million in 2025.
  • Its Income towards Parent Company was -$21.1 million in Q3 2025, compared to -$23.2 million in Q2 2025 and -$22.8 million in Q1 2025.